or
forgot password
  • cancer clinical trials in tupelo, MS

  • Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Lung Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    North Mississippi Hematology And Oncology Associates, Ltd
    Tupelo, Mississippi 38801
    Prostatic Neoplasms
    Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
    North Mississippi Hematology And Oncology Associates, Ltd
    Tupelo, Mississippi 38801
    Non-small Cell Lung Cancer (NSCLC)
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10015 Boehringer Ingelheim Investigational Site
    Tupelo, Mississippi
    Breast Neoplasms
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tupelo, Mississippi
    Rheumatoid Arthritis
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    North Mississippi Hematology & Oncology
    Tupelo, Mississippi 38801
    Chronic Myeloid Leukemia
    Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
    North Mississippi Hematolgy and Oncology Associates, ltd
    Tupelo, Mississippi 38801
    Hepatocellular Carcinoma
    Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
    North Mississippi Health Services
    Tupelo, Mississippi 38801
    Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    North Mississippi Hematology And Oncology Associates, Ltd
    Tupelo, Mississippi 38801
    Renal Cell Carcinoma
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Tupelo, Mississippi 38801
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Tupelo, Mississippi 38801
    Muscle Wasting, Non-Small Cell Lung Cancer
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Hematology and Oncology Associates at BridgePoint
    Tupelo, Mississippi 38801
    Pancreatic Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Hematology and Oncology Associates at BridgePoint
    Tupelo, Mississippi 38801
    Colorectal Cancer
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    Cardiology Asociates Research LLC
    Tupelo, Mississippi 38801
    ST Segment Elevation Myocardial Infarction
    Afatinib Expanded Access Program
    1200.45.036 Boehringer Ingelheim Investigational Site
    Tupelo, Mississippi
    Carcinoma, Non-Small-Cell Lung
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Lung Cancer
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Prostate Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Metastatic Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Diarrhea, Radiation Enteritis
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    North Mississippi Hematology and Oncology Associates, Limited
    Tupelo, Mississippi 38801
    Breast Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Brain and Central Nervous System Tumors
    Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
    North Mississippi Hematology and Oncology Associates, Ltd.
    Tupelo, Mississippi 38801
    Breast Cancer
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    North Mississippi Medical Center/Cancer Center
    Tupelo, Mississippi 38801
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Genetic Study of Young Patients With Colorectal Cancer
    Digestive Health Specialists, P.A.
    Tupelo, Mississippi 38801
    Colorectal Cancer
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    North Mississippi Hematology & Oncology Associates, Ltd.
    Tupelo, Mississippi 38801
    Prostate Cancer
    Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
    N. Mississippi Hematology & Oncology Associates
    Tupelo, Mississippi 38801
    Pancreatic Cancer
    A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tupelo, Mississippi
    Colorectal Cancer
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    North Missssppi Hematology Oncology Associates
    Tupelo, Mississippi 38801
    Diffuse Large-Cell Lymphoma
    Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
    North Mississippi Hematology & Oncology Associates, Ltd.
    Tupelo, Mississippi 38801
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    TroVax Renal Immunotherapy Survival Trial
    Haematology and Oncology Associates at Bridgeport
    Tupelo, Mississippi 38801
    Clear Cell Renal Carcinoma
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Tupelo Neurology Clinic, Pa
    Tupelo, Mississippi 38801
    Atrial Fibrillation, Atrial Flutter
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Hematology & Oncology Associates at Bridgeport
    Tupelo, Mississippi 38801
    Cachexia
    Chemoprevention of Colorectal Adenomas
    Digestive Health Specialists, PA
    Tupelo, Mississippi 38801
    Adenomatous Polyps
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Tupelo Neurology Clinic, Pa
    Tupelo, Mississippi 38801
    Multiple Sclerosis, Relapsing-Remitting
    Cognition in the Study of Tamoxifen and Raloxifene
    Hematology & Oncology Associates Ltd
    Tupelo, Mississippi 38801
    Cognition, Aging
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840059
    Tupelo, Mississippi 38801
    Venous Thromboembolism, Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Digestive Health Specialists
    Tupelo, Mississippi 38801
    Crohn's Disease
    Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6
    Hematology and Oncology Assoc. at Bridgeport
    Tupelo, Mississippi 38801
    Colon Cancer With Metastases to the Liver
    A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
    North Mississippi Hematology & Oncology Associates, Ltd.
    Tupelo, Mississippi 38801
    Renal Cell Carcinoma